Total number of projects: 6
As coordinator: 2
As participant: 4
Sole participant: 0
Coordinator / Participant Ratio: 0.5*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2019 | 0 | 2.588.829 | 510.186 | 1 | ||
2013 | 0 | 2.491.014 | 336.000 | 1 | ||
2011 | 5.516.001 | 11.981.710 | 661.000 | 1 | 1 | |
2010 | 12.000.000 | 2.784.402 | 3.159.857 | 1 | 1 |
Total number of partners: 3529
Partner loyalty:
Frequent Partner: (> 2 projects): 1814
Rare Partner: 1715
Frequent / Rare Partner Ratio: 1.06
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2019-03-01 | NAtuRal instability of semiConductors thIn SOlid films for sensing and photonic applications | NARCISO | participant | 2.588.829 | 6 |
2013-05-01 | Understanding and exploiting complex glycan metabolism in the human microbiota | HUMAN MICROBIOTA | participant | 2.491.014 | 2 |
2011-01-01 | Novel multimodal endoscopic probes for simultaneous PET/ultrasound imaging for image-guided interventions | EndoTOFPET-US | coordinator | 5.516.001 | 15 |
2011-01-01 | Biology and control of vector-borne infections in Europe | EDENext | participant | 11.981.710 | 52 |
2010-11-01 | Vector-borne Risks for Europe: Risk assessment and control of West Nile and Chikungunya virus (VECTORIE) | VECTORIE | participant | 2.784.402 | 9 |
2010-10-01 | Small-molecule Inhibitor Leads Versus emerging and neglected RNA viruses | SILVER | coordinator | 12.000.000 | 24 |